Home » Topics » BioWorld MedTech

BioWorld MedTech
RSS

CHIRON TO RECEIVE BRITISH PATENT

Dec. 18, 1991

IMMUNEX PATENT FOR FUSION MOLECULE

Dec. 18, 1991

PROTEIN DESIGN FILES FOR IPO

Dec. 18, 1991

SANDOZ DEAL FOR SYSTEMIX: $392M FOR 60%

Dec. 17, 1991

MOUSE EXPRESSES HUMAN ANTIBODIES

Dec. 17, 1991

GILEAD FILES FOR 3 MILLION-SHARE IPO

Dec. 17, 1991

ONCOR FILES FOR 3 MILLION-SHARE OFFERING

Dec. 17, 1991

U.S. BIO SPLITS STOCK 2 FOR 1

Dec. 17, 1991

3M TO EVALUATE LIPOSOMAL GENTAMICIN

Dec. 17, 1991

AIDS DRUG EFFECTIVE IN EARLY TRIALS

Dec. 17, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 20, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 20, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...